These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28496098)

  • 1. Combined treatment with Metformin and 2-deoxy glucose induces detachment of viable MDA-MB-231 breast cancer cells in vitro.
    Bizjak M; Malavašič P; Dolinar K; Pohar J; Pirkmajer S; Pavlin M
    Sci Rep; 2017 May; 7(1):1761. PubMed ID: 28496098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the AMP-kinase modulators AICAR, metformin and compound C on insulin secretion of INS-1E rat insulinoma cells under standard cell culture conditions.
    Langelueddecke C; Jakab M; Ketterl N; Lehner L; Hufnagl C; Schmidt S; Geibel JP; Fuerst J; Ritter M
    Cell Physiol Biochem; 2012; 29(1-2):75-86. PubMed ID: 22415077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of metformin alone is not associated with survival outcomes of colorectal cancer cell but AMPK activator AICAR sensitizes anticancer effect of 5-fluorouracil through AMPK activation.
    Sui X; Xu Y; Yang J; Fang Y; Lou H; Han W; Zhang M; Chen W; Wang K; Li D; Jin W; Lou F; Zheng Y; Hu H; Gong L; Zhou X; Pan Q; Pan H; Wang X; He C
    PLoS One; 2014; 9(5):e97781. PubMed ID: 24849329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin synergizes 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) combination therapy through impairing intracellular ATP production and DNA repair in breast cancer stem cells.
    Soo JS; Ng CH; Tan SH; Malik RA; Teh YC; Tan BS; Ho GF; See MH; Taib NA; Yip CH; Chung FF; Hii LW; Teo SH; Leong CO
    Apoptosis; 2015 Oct; 20(10):1373-87. PubMed ID: 26276035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medium Renewal Blocks Anti-Proliferative Effects of Metformin in Cultured MDA-MB-231 Breast Cancer Cells.
    Rajh M; Dolinar K; Miš K; Pavlin M; Pirkmajer S
    PLoS One; 2016; 11(5):e0154747. PubMed ID: 27135408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMPK activators suppress breast cancer cell growth by inhibiting DVL3-facilitated Wnt/β-catenin signaling pathway activity.
    Zou YF; Xie CW; Yang SX; Xiong JP
    Mol Med Rep; 2017 Feb; 15(2):899-907. PubMed ID: 28035400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin and AICAR regulate NANOG expression via the JNK pathway in HepG2 cells independently of AMPK.
    Shen C; Ka SO; Kim SJ; Kim JH; Park BH; Park JH
    Tumour Biol; 2016 Aug; 37(8):11199-208. PubMed ID: 26939902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIK3CA mutation sensitizes breast cancer cells to synergistic therapy of PI3K inhibition and AMPK activation.
    Liu S; Tang Y; Yan M; Jiang W
    Invest New Drugs; 2018 Oct; 36(5):763-772. PubMed ID: 29504069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMPK inhibits MTDH expression via GSK3β and SIRT1 activation: potential role in triple negative breast cancer cell proliferation.
    Gollavilli PN; Kanugula AK; Koyyada R; Karnewar S; Neeli PK; Kotamraju S
    FEBS J; 2015 Oct; 282(20):3971-85. PubMed ID: 26236947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMPK Activation of Apoptotic Markers in Human Breast Cancer Cell Lines with Different p53 Backgrounds: MCF-7, MDA-MB-231 and T47D Cells.
    El-Masry OS; Brown BL; Dobson PRM
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3763-3770. PubMed ID: 31870119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic profiling of attached and detached metformin and 2-deoxy-D-glucose treated breast cancer cells reveals adaptive changes in metabolome of detached cells.
    Repas J; Zügner E; Gole B; Bizjak M; Potočnik U; Magnes C; Pavlin M
    Sci Rep; 2021 Nov; 11(1):21354. PubMed ID: 34725457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of AMPK agonists on cell growth and metabolism.
    Vincent EE; Coelho PP; Blagih J; Griss T; Viollet B; Jones RG
    Oncogene; 2015 Jul; 34(28):3627-39. PubMed ID: 25241895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMPK Re-Activation Suppresses Hepatic Steatosis but its Downregulation Does Not Promote Fatty Liver Development.
    Boudaba N; Marion A; Huet C; Pierre R; Viollet B; Foretz M
    EBioMedicine; 2018 Feb; 28():194-209. PubMed ID: 29343420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AICAR and Metformin Exert AMPK-dependent Effects on INS-1E Pancreatic β-cell Apoptosis via Differential Downstream Mechanisms.
    Dai YL; Huang SL; Leng Y
    Int J Biol Sci; 2015; 11(11):1272-80. PubMed ID: 26435693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention.
    Zordoky BN; Bark D; Soltys CL; Sung MM; Dyck JR
    Biochim Biophys Acta; 2014 Jun; 1840(6):1943-57. PubMed ID: 24462945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Treatment of MCF-7 Cells with AICAR and Methotrexate, Arrests Cell Cycle and Reverses Warburg Metabolism through AMP-Activated Protein Kinase (AMPK) and FOXO1.
    Fodor T; Szántó M; Abdul-Rahman O; Nagy L; Dér Á; Kiss B; Bai P
    PLoS One; 2016; 11(2):e0150232. PubMed ID: 26919657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5'-AMP-activated protein kinase (AMPK) regulates progesterone receptor transcriptional activity in breast cancer cells.
    Wu L; Huang XJ; Yang CH; Deng SS; Qian M; Zang Y; Li J
    Biochem Biophys Res Commun; 2011 Dec; 416(1-2):172-7. PubMed ID: 22093824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMP-activated protein kinase agonists increase mRNA content of the muscle-specific ubiquitin ligases MAFbx and MuRF1 in C2C12 cells.
    Krawiec BJ; Nystrom GJ; Frost RA; Jefferson LS; Lang CH
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1555-67. PubMed ID: 17264220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances on the anti-inflammatory and protective effect of AMPK activators].
    Peng XW; Zhou HH; Dai J; Zhang L
    Sheng Li Xue Bao; 2019 Apr; 71(2):319-326. PubMed ID: 31008492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
    Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP
    Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.